In the intricate chain of pharmaceutical production, pharmaceutical intermediates are the unsung heroes—critical building blocks that bridge raw materials and finished drugs, demanding precision, purity, and consistency. For Shijiazhuang Kunxiangda Technology Co., Ltd., perfecting these intermediates has been a decade-long mission. Since 2011, this Shijiazhuang-based enterprise has grown from a focused manufacturer to a trusted global partner, specializing in high-quality pharmaceutical intermediates like the versatile 1,3-dimethylurea (DMU) and potent active pharmaceutical intermediates (APIs) that power drugs worldwide. With a 50-acre production base, a team of 300+ employees (including 9 dedicated technicians), and collaborations with top universities, Kunxiangda doesn’t just produce intermediates—it sets benchmarks for quality. Exported to Europe, South America, and beyond, their products embody the idea that “perfection” isn’t an accident—it’s the result of expertise, innovation, and a commitment to customer trust.
Kunxiangda’s Pharmaceutical Intermediates Journey: 13 Years of Precision
Shijiazhuang Kunxiangda Technology Co., Ltd. was founded in 2011 with a clear vision: to fill the gap for reliable, high-purity pharmaceutical intermediates in both domestic and global markets. Back then, the pharmaceutical industry faced a challenge: many intermediates lacked consistent quality, leading to delays in drug production and increased costs. Kunxiangda stepped in, focusing first on mastering the production of 1,3-dimethylurea—a versatile intermediate with applications in both pharmaceuticals and materials.
From a modest start, Kunxiangda expanded rapidly. Today, its factory in Shijiazhuang’s Economic and Technological Development Zone spans 50 acres, equipped with advanced production lines that meet strict industry standards. What truly sets Kunxiangda apart is its investment in people and technology: 9 professional technicians oversee every step of production, from raw material selection to final packaging, ensuring zero defects. The company also built a dedicated procurement team to help foreign clients source the best domestic materials, earning a reputation for reliability. Over 13 years, Kunxiangda has grown from a local player to a global supplier, with products reaching dozens of countries. For them, pharmaceutical intermediates aren’t just chemicals—they’re a promise to drug manufacturers: “You can trust our products to power your life-saving drugs.”
1,3-Dimethylurea: Kunxiangda’s Versatile Pharmaceutical Intermediate
1,3-dimethylurea (DMU) is one of Kunxiangda’s flagship products, a multi-functional pharmaceutical intermediate that shines in both pharmaceutical and industrial applications. Its popularity stems from its high purity, consistent quality, and wide utility—and Kunxiangda’s DMU is engineered to meet the most demanding standards. Below is a detailed breakdown of its parameters and why it’s a top choice for clients:
|
Parameter |
Specification |
Benefit for Clients |
|
Product Details |
Name: N,N’-Dimethyl urea (1,3-Dimethylurea); CAS No.: 96-31-1 |
Standardized identification ensures compatibility with global production processes (critical for international drug makers). |
|
Molecular Properties |
Formula: C₃H₈N₂O; Molecular Weight: 88.1 |
Stable molecular structure ensures consistent performance in drug synthesis (e.g., no batch-to-batch variations). |
|
Key Uses |
Pharmaceutical: Prepares caffeine, theophylline, metformin; Industrial: Fiber treatment agent, preservative |
Versatility reduces clients’ need to source multiple intermediates—saves time and logistics costs. |
|
Packaging & Loading |
25kg/bag; 12mt/20FCL (with pallets) |
Bulk packaging suits large-scale production; pallets ensure safe, efficient shipping (minimizes damage during transit). |
|
Storage Requirements |
Dry, ventilated storeroom; avoid direct sunlight; light stacking |
Easy storage reduces waste; stable under standard conditions (no special equipment needed). |
Kunxiangda’s 1,3-dimethylurea stands out for its purity—achieved through advanced purification processes developed with university partners. For a pharmaceutical company making metformin (a common diabetes drug), this purity means fewer impurities in the final product, reducing regulatory risks. For a textile manufacturer using DMU as a fiber treatment agent, its consistency ensures uniform results across batches. It’s this attention to detail that makes Kunxiangda’s DMU a global favorite.
Active Pharmaceutical Intermediates: Kunxiangda’s Engine for Drug Innovation
While 1,3-dimethylurea serves multiple industries, Kunxiangda’s active pharmaceutical intermediates (APIs) are laser-focused on powering drug development. APIs are the “active” components that give drugs their therapeutic effect, and their quality directly impacts drug safety and efficacy—making precision non-negotiable. Kunxiangda’s active pharmaceutical intermediates (including 6-Amino-1,3-dimethyluracil and 6-Chloro-1,3-dimethyluracil) are developed in collaboration with Tsinghua University and Hebei University of Science and Technology, ensuring their technical level leads both domestic and international markets.
The company’s API production follows strict quality control: raw materials are sourced from trusted suppliers, production lines are regularly calibrated, and every batch undergoes rigorous testing (for purity, solubility, and stability). For example, their 6-Amino-1,3-dimethyluracil (DMAU) is used to synthesize antiviral drugs—so Kunxiangda ensures it meets the strictest impurity limits (below 0.1%), a standard that many competitors struggle to match. Kunxiangda also invests in R&D to reduce API production costs without compromising quality, helping drug manufacturers bring affordable medicines to market. For pharmaceutical companies, partnering with Kunxiangda for active pharmaceutical intermediates isn’t just about sourcing materials—it’s about gaining a collaborator that understands the stakes of drug development.
FAQs: Pharmaceutical Intermediates, 1,3-Dimethylurea & APIs
Pharmaceutical intermediates: Export globally?
Yes! Kunxiangda’s pharmaceutical intermediates are exported to Europe, South America, Asia, the Middle East, and dozens of other regions, with a mature global marketing network ensuring timely delivery.
1,3-Dimethylurea: For metformin?
Absolutely. Kunxiangda’s 1,3-dimethylurea is a key raw material for metformin (a diabetes drug), with high purity (low impurities) meeting pharmaceutical production standards.
Active parmaceutical intermediates: Quality tested?
Yes. Every batch of active pharmaceutical intermediates undergoes strict testing (purity, stability) to ensure safety and efficacy.
1,3-Dimethylurea: Bulk supply?
Yes. It’s packed in 25kg/bags, with 12mt per 20FCL—ideal for large-scale production.
Why choose Kunxiangda for pharmaceutical intermediates?
Choose Kunxiangda for 13 years of expertise, university-backed R&D, and quality pharmaceutical intermediates (1,3-DMU, APIs) trusted globally.
Kunxiangda’s journey to perfect pharmaceutical intermediates is rooted in Shijiazhuang’s industrial heritage—yet its impact is global. From the versatile 1,3-dimethylurea that bridges pharmaceuticals and materials to the precision-engineered active pharmaceutical intermediates that power life-saving drugs, every product reflects the company’s ethos: “Harmony, integrity, development, win-win.” For drug manufacturers, textile producers, and global clients, Kunxiangda isn’t just a supplier—it’s a partner in perfection. In Shijiazhuang, the future of pharmaceutical intermediates is already here—and it’s built on Kunxiangda’s commitment to quality.